Clinical Trial

Trial Protocol ID USOR 22229_DS1062-A-U303_TROPION-Lung07

Trial Description

A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or Without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung07)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Andrew Mener, M.D.

Disease Types

Sponsor

  • DAIICHI SANKYO PHARMA DEVELOPMENT; Syneos Health

ClinicalTrials.gov NCT ID

  • NCT05555732